Options available through our program include: Semaglutide (GLP-1 receptor agonist) available as a weekly injection that suppresses appetite and regulates blood sugar Mounjaro (tirzepatide) a newer dual-receptor medication associated with significant weight reduction in clinical trials FDA-approved appetite suppressants tailored to your metabolic profile Vitamin B12 and IV therapy to support energy, metabolism, and overall wellness Patients interested in how IV therapy complements a weight loss plan can explore our IV therapy for weight loss page for more details
Xie Y et al
Stop taking Mucinex and talk to your doctor if you develop a cough that is accompanied by a fever, a rash, or a headache that won't go away
Tirzepatide is not recommended for patients with severe gastrointestinal disease, including severe gastroparesis, due to its effects on gastric emptying
CrossRef Stage-dependent dynamics of Apolipoprotein C3 across the spectrum of MASLD Eva Katharina Messer, Janett Fischer, Toni Herta, Albrecht Boehlig, Madlen Matz-Soja, Adrienn Tuennemann-Tarr, Susanne Gaul, Ulrich Laufs, Thomas Berg, Pavel Strnad PLOS One .2026
In a tracking poll, about 32% of people said theyd heard a lot about GLP-1 drugs, up 19% since 2018